Study finds Bharat Biotech’s rotovac vaccine is linked to higher risk of bowel condition in infants: Report

Study finds Bharat Biotech’s rotovac vaccine is linked to higher risk of bowel condition in infants: Report

New Delhi: An indigenous vaccine Rotovac, manufactured for the rotavirus vaccine Bharat Biotech also included in the government’s vaccination campaign, has been linked with an increased risk of intussusception in infants, reported Economic Times citing a recent study conducted by the International Journal of Risk and Safety in Medicine.

According to the study and its co-author Jacob Puliyel, MD of International Institute of Health Management Research, India and Brain Hooker of Children’s Health Defense, revealed a 1.6-fold raised risk of intussusception among babies who are vaccinated, which was not earlier detected in previous analyses.

What is Intussusception?

According to Cleveland Clinic, Intussusception is a condition in which one segment of the intestine ‘telescopes’ inside of another causing an intestinal blockage. However, intussusception can take place anywhere in the gastrointestinal tract area or bowel area, it usually takes place at the junction of the small and large intestines. The blockage can cause swelling and inflammation that can cause intestinal injury.

However, the cause of intussusception is yet not known but in most cases, it is thought that the virus produces swelling of the lining of the intestine, which then slips into the intestine below. In some kids, it is caused by a condition that the child is born with a polyp or diverticulum.

Symptoms of intussusception

As per the report, the major symptom of intussusception is serious which includes abdominal pain alternating with periods of no pain. The painful time may last for 10 to 15 minutes or more than that. Also, this may be followed by periods of 20 to 30 minutes of no pain, after that the pain returns. Other symptoms may include:

Nausea.
Vomiting.
Rectal bleeding (red jelly-like stools)
Sometimes mixed with mucus.

Earlier in 2020, a New England Journal of Medicines study revealed that there was no risk of intussusception from Rotovac, a live attenuated rotavirus vaccine.

 The study revealed a 1.6-fold raised risk of intussusception among babies who are vaccinated, which was not earlier detected in previous analyses, however, earlier in 2020, a New England Journal of Medicines study found that there was no risk of intussusception from Rotovac, a live attenuated rotavirus vaccine.   Health Conditions Health News: Latest News from Health Care, Mental Health, Weight Loss, Disease, Nutrition, Healthcare